One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Repolarization Heterogeneity in Human Post-Infarct Ventricular Tachycardia
David J. Callans, MD, a J. Kevin Donahue, MD
doi : 10.1016/j.jacep.2022.03.002
Volume 8, Issue 6, June 2022, Pages 713-718
Slow conduction, caused by fibrosis between surviving myocytes and connexin remodeling, is an important prerequisite for post-infarction ventricular tachycardia (VT); however, slow conduction is present throughout the infarct whereas VT circuits are finite in number and discrete.
Rediscovering Repolarization∗: Timing Is Everything
Pier D. Lambiase, BM BC H , PHD
doi : 10.1016/j.jacep.2022.04.009
Volume 8, Issue 6, June 2022, Pages 719-721
Pulsed Field Ablation of Left Ventricular Myocardium in a Swine Infarct Model
Sung Il Im, MD, PHD, a Satoshi Higuchi, MD, PHD, a Adam Lee, MBBS, MM ED (CLIN EPI), a Carol Stillson, RVT, a Eric Buck, MS, b Blake Morrow, MS,b Kit Schenider, ME NG ,b Molly Speltz, DVM,c Edward P. Gerstenfeld, MD
doi : 10.1016/j.jacep.2022.03.007
Volume 8, Issue 6, June 2022, Pages 722-731
Pulsed field ablation (PFA) leads to cell death by irreversible electroporation. There are limited data about PFA lesion characteristics in the ventricle, particularly in the presence of myocardial scar.
Are We Ready for the Next Frontier: PFA in the Ventricle?∗
Nishaki K. Mehta, MD, David E. Haines, MD
doi : 10.1016/j.jacep.2022.05.004
Volume 8, Issue 6, June 2022, Pages 732-734
Coagulation Response and Prothrombotic Effect of Uninterrupted Oral Anticoagulant Administration After Catheter Ablation for VT
Satoshi Yanagisawa, MD, P HD, a,b Yasuya Inden, MD, P HD, b Shuro Riku, MD,b Koichi Furui, MD, b Kazumasa Suga, MD, b Toshifumi Nakagomi, MD,b Masafumi Shimojo, MD,b Takashi Okajima, MD,b Ryo Watanabe, MD, b Naoki Tsurumi, MD,b Noriyuki Suzuki, MD,b Rei Shibata, MD, PH D, a Toyoaki Murohara, MD, PH D
doi : 10.1016/j.jacep.2022.02.015
Volume 8, Issue 6, June 2022, Pages 735-748
Catheter ablation for ventricular tachycardia (VT) is associated with perioperative thromboembolic risk. However, the strategy for postprocedural management remains unknown.
Uninterrupted Oral Anticoagulation During Catheter Ablation of Ventricular Tachycardia: Is the Riskier Option the Safest?∗
Jorge E. Romero, MD,a Samuel Z. Goldhaber, MD
doi : 10.1016/j.jacep.2022.04.007
Volume 8, Issue 6, June 2022, Pages 749-753
Reduction in Ventricular Tachyarrhythmia Burden in Patients Enrolled in the RAIDÂ Trial
Arwa Younis, MD, a,b Ilan Goldenberg, MD, a Shamroz Farooq, MD, a Hagai Yavin, MD, b James Daubert, MD, c Merritt Raitt, MD,d Alexander Mazur, MD, e David T. Huang, MD,a Brent L. Mitchell, MD,f Mayer R. Rashtian, MD,g Stephen Winters, MD,h Margot Vloka, MD,i Mehmet Aktas, MD, a Matthew A. Bernabei, MD,j Christopher A. Beck, PHD, k Scott McNitt, MS,a Wojciech Zareba, MD, P HD
doi : 10.1016/j.jacep.2022.02.018
Volume 8, Issue 6, June 2022, Pages 754-762
The RAID (Ranolazine Implantable Cardioverter-Defibrillator) randomized placebo-controlled trial showed that ranolazine treatment was associated with reduction in recurrent ventricular tachycardia (VT) requiring appropriate implantable cardioverter-defibrillator (ICD) therapy.
A Role for Ranolazine in the Treatment of Ventricular Arrhythmias?∗
Jason G. Andrade, MD, a Marc W. Deyell, MD, MS C
doi : 10.1016/j.jacep.2022.04.010
Volume 8, Issue 6, June 2022, Pages 763-765
Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry
Mohamad Alkhouli, MD,a Chengan Du, P HD, b Ammar Killu, MD, a Trevor Simard, MD, a Peter A. Noseworthy, MD, a Paul A. Friedman, MD,a Jeptha P. Curtis, MD,b James V. Freeman, MD, b David R. Holmes, MD
doi : 10.1016/j.jacep.2022.03.001
Volume 8, Issue 6, June 2022, Pages 766-778
Data on the impact of residual peri-device leak after left atrial appendage occlusion (LAAO) are limited.
Peri-Device Leak After Left Atrial Appendage Occlusion: Minding the Gap∗
James K. Gabriels, MD, Christopher F. Liu, MD
doi : 10.1016/j.jacep.2022.04.008
Volume 8, Issue 6, June 2022, Pages 779-781
Comparison of 2 Smart Watch Algorithms for Detection of Atrial Fibrillation and the Benefit of Clinician Interpretation: SMART WARS Study
Christopher Ford, MD, a Charis Xuan Xie, MS C, MR ES,a Ashlea Low, MBBS, a Kevin Rajakariar, MBBS, a Anoop N. Koshy, MBBS, a,b Jithin K. Sajeev, MBBS, PH D, a Louise Roberts, PHD, a Bhupesh Pathik, MBBS, PH D, a Andrew W. Teh, MBBS, PHD
doi : 10.1016/j.jacep.2022.02.013
Volume 8, Issue 6, June 2022, Pages 782-791
Smart watches and wearable technology capable of heart rhythm assessment have increased in use in the general population. The Apple Watch Series 4 (AW4) and KardiaBand (KB) are devices capable of obtaining single-lead electrocardiographic recordings, presenting a novel opportunity for the detection of paroxysmal arrhythmias.
Getting Smart About Wearable ECG Interpretation in the Clinic∗
Marco V. Perez, MD
doi : 10.1016/j.jacep.2022.03.018
Volume 8, Issue 6, June 2022, Pages 792-794
Feasibility of Assessing Cryoballoon Pulmonary Vein Occlusion With Saline Injection and a Novel Mapping System
Mahmoud Houmsse, MD, a Faisal Matto, MD, a Matthew S. Sulkin, P HD, b David J. Tomaszewski, PA, b Sergei Shulepov, P HD, b Lior Glassner, BS C,b Ralph Augostini, MD,a Steven Kalbfleisch, MD, a Emile G. Daoud, MD,a John Hummel, MD
doi : 10.1016/j.jacep.2022.04.011
Volume 8, Issue 6, June 2022, Pages 795-799
Thirty-eight patients had assessment of pulmonary vein occlusion with the dielectric mapping system and injection of saline as an alternative to contrast. Contrast injection was required to ascertain pulmonary vein occlusion in 31.6% (12 of 38) of subjects and 17.4% (27 of 155) of veins.
Magnesium in the Management of Atrial Fibrillation With Rapid Ventricular Response
Jason Nogic, MBBS, MMedy Michael MacPherson, MBChBy Emogene Aldridge, BHIthSc, MPH Jithin K. Sajeev, MBBS, PhD Louise Roberts, PhD David Lowman, MBBS Serena Sze, MBBS Alex Kwong, MBBS Paul Buntine, MBBS, MClinRes *Andrew W. Teh, MBBS, PhD
doi : 10.1016/j.jacep.2022.01.017
Volume 8, Issue 6, June 2022, Pages 800-802
Paroxysmal Heart Block After Orthotopic Heart Transplant: Evidence of Intrinsic Cardiac Nerve Activity
Thomas Flautt, DO Adi Lador, MD *Miguel Valderrábano, MD
doi : 10.1016/j.jacep.2022.02.006
Volume 8, Issue 6, June 2022, Pages 802-803
Percutaneous Vascular Closure Compared With Manual Compression in Atrial Fibrillation Ablation
Soroosh Kiani, MD, MS Joel Eggebeen, MS Mikhael F. El-Chami, MD Anand D. Shah, MD Stacy B. Westerman, MD David B. De Lurgio, MD Faisal M. Merchant, MD Neal K. Bhatia, MD Angel R. Leon, MD Michael S. Lloyd, MD
doi : 10.1016/j.jacep.2022.02.016
Volume 8, Issue 6, June 2022, Pages 803-805
Latent Causes of Sudden Cardiac Arrest
Andrew D. Krahn, MD, a Jacob Tfelt-Hansen, MD, DMSC ,b,c Rafik Tadros, MD, P HD, d Christian Steinberg, MD,e Christopher Semsarian, MBBS, P H D, MPH,f Hui-Chen Han, MBBS, PHD
doi : 10.1016/j.jacep.2021.12.014
Volume 8, Issue 6, June 2022, Pages 806-821
Inherited arrhythmia syndromes are a common cause of apparently unexplained cardiac arrest or sudden cardiac death. These include long QT syndrome and Brugada syndrome, with a well-recognized phenotype in most patients with sufficiently severe disease to lead to cardiac arrest.
Incidence and Outcomes of Patients With Watchman FLX “Fluttering�
Mohit K. Turagam, MD, a Shephal K. Doshi, MD,b Iwanari Kawamura, MD,a Srinivas R. Dukkipati, MD, a Pavel Hala, MD,c Petr Neuzil, MD, c Vivek Y. Reddy, MD
doi : 10.1016/j.jacep.2022.02.010
Volume 8, Issue 6, June 2022, Pages 822-823
Mapping of Left Bundle Anatomy in Left Ventricle Facilitates Left Bundle Pacing
Abhishek Gupta, MD, Vikas Kataria, MD, Pritam Kitey, MD, Mohan Nair, MD
doi : 10.1016/j.jacep.2022.03.005
Volume 8, Issue 6, June 2022, Pages 824-827
Comparative Endothelialization of Amulet LAA Occluder and Watchman 2.5Â LAA Device: Observations From Explanted Hearts
Christopher R. Ellis, MD,a Mohamad Alkhouli, MD, b Jordan A. Anderson, P HD, c Vijendra Swarup, MD
doi : 10.1016/j.jacep.2022.01.024
Volume 8, Issue 6, June 2022, Pages 828-829
